18 results with keyword: 'role autologous allogeneic stem transplantation follicular lymphoma drugs'
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as
N/A
AITL, angioimmunoblastic T-cell lymphoma; alloSCT, allogeneic stem cell transplantation; autoSCT, autologous stem cell transplantation; A-BMT, autologous bone marrow transplant;
N/A
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin’s lymphoma relapsing after an autologous stem-cell transplantation:
N/A
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma:
N/A
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a
N/A
Myeloablative radiochemo- therapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: Results of
N/A
Allogeneic stem-cell trans- plantation as salvage therapy for pa- tients with diffuse large B-cell non Hod- gkin’s lymphoma relapsing after an autologous stem-cell transplantation:
N/A
autologous stem cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol.. Freedman
N/A
Arm 20: Procedure: allogeneic hematopoietic stem cell transplantation Arm 20: Procedure: autologous hematopoietic stem cell transplantation Arm 20: Procedure: peripheral blood stem
N/A
Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Extranodal NK/T-Cell Lymphoma, Nasal Type: Analysis of the Japan Society for Hematopoietic
N/A
Long- term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin
N/A
(1999) High dose therapy (HDT) and autologous blood stem cell (ABSC) transplantation versus conventional treatment in multiple myeloma (MM): results of a randomized trial in
N/A
Supervised by Jordan Lachler at Canadian Indigenous Languages and Literacy Development Institute (CILLDI), University of Alberta..
N/A
Despite the introduction of autologous stem cell transplantation and more recently novel agents, such as lenalido- mide and bortezomib, allogeneic stem cell transplantation
N/A
Keywords: Fact-BMT, Quality of life, Arabic translation, Translation and validation, Bone marrow transplant, Stem cell transplantation, Autologous stem cell transplantation,
N/A
Rocha, HLA- identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem
N/A
AITL: angioimmunoblastic T-cell lymphoma; ALCL: anaplastic large cell lymphoma; ALK: anaplastic lymphoma kinase; ASCT: autologous stem cell transplantation; CHOP: cyclophosphamide
N/A
Autologous fecal microbiota transplantation (auto-fmt) for prophylaxis of clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation
N/A